Transcript document

CORPORATE SOCIAL RESPOSIBILITY

PRESENTED BY
–
–
D SHREE VENKATESH
[email protected]
Novartis was created in 1996 through the merger
of Ciba-Geigy and Sandoz, two companies with a
rich and diverse corporate history.
Throughout the years, Novartis and its
predecessor companies have discovered and
developed many innovative products for patients
and consumers worldwide.
Novartis Foundation for Sustainable Development (NFSD)

NFSD have long been involved to fight against
leprosy.

Since 2000 Novarties has been working with the
World Health Organization (Geneva) to provide free
multi drug treatment against leprosy patients in the
world till the end of the year 2010.

This has led to the cure of 4.5 million patients so far.
Novartis Comprehensive Leprosy Care Association (NCLCA)

A project sponsored by NFSD and Novartis India,
helps recovering leprosy patients with both physical
and social rehabilitation, including income generation
assistance.

The NCLCA has pioneered an integrated system of
prevention, correction, care and rehabilitation.

At a global level, Novartis access-to-medicines
programs in 2006 reached over 33 million patients
worldwide, with contributions totaling USD 755
million.

In India, Novartis undertakes initiatives in the areas of
tuberculosis, leprosy and oncology as well as
education and vocational training of and for the
underprivileged.
AWARDS RECIEVED

February 6, 2008 - Novartis India received the
Reader's Digest Pegasus CSR Gold Award in
Mumbai on December 12.

The award, in the "Contribution to individual welfare"
category, recognizes the work the company has
done in rehabilitating leprosy patients in India.
RECOGNITIONS

National Organization for Rare Disorders Corporate
Award, Novartis honored for its research on rare diseases,
May 2010

DiversityInc Top 10 Global Diversity Companies,
Novartis No. 7 in top 10 companies for global diversity in
2010, May 2010

The Scientist Best Places to Work in Industry 2010,
Novartis ranked as one of the best places to work in
industry, April 2010

The Scientist's Best Places To Work, Novartis ranked
No. 7 top workplace among large companies in 2009, April
2010
OTHER RECOGNITIONS


Fortune's World's Most Admired Companies,
Novartis among the top three pharmaceutical
companies, March 2010
The Scientist's Best Places To Work for
Postdocs, three locations of the Novartis Institutes
for BioMedical Research (NIBR) recognized in The
Scientist's 2010 ranking of the “Best Places to Work
for Postdocs,” March 2010